OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
June 23, 2021
Advice for community physicians and gastroenterologists to help manage patients with ulcerative colitis.
Drs Maria T. Abreu and Timothy Ritter comment on limitations faced by providers who treat patients with ulcerative colitis and highlight strategies under investigation that can improve how the disease is managed.
Implications for treating patients with ulcerative colitis with novel S1P receptor modulators based on data revealed by the phase 2 OASIS trial, which has now led to a phase 3 study, ELEVATE UC 52.
June 18, 2021
Limitations that physicians and patients face when selecting therapy for ulcerative colitis.